Lv6
2555 积分 2021-05-19 加入
Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma
22小时前
待确认
Theranostics in Lung Neuroendocrine Tumors
10天前
已完结
Selecting systemic treatment for metastatic neuroendocrine tumors of the lung—current evidence and clinical implications
10天前
已完结
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies
10天前
已完结
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
1个月前
已完结
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study
1个月前
已完结
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
1个月前
已完结
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
1个月前
已完结
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
1个月前
已完结
Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
2个月前
已完结
皖公网安备34019202002308
